.AstraZeneca has actually shared an early check out the efficiency of its own in-house antibody-drug...
.After announcing a stage 3 launch based on favorable midstage outcomes, iTeos and also GSK are fina...
.The FDA needs to be much more open and joint to let loose a rise in commendations of rare health co...
.It's an extraordinarily busy Friday for biotech IPOs, along with Zenas BioPharma, MBX and also Bica...
.Atea Pharmaceuticals' antiviral has actually stopped working an additional COVID-19 trial, however ...
.Neurocrine Biosciences' mental illness program pivot has actually stopped working. The biotech was ...
.Sanofi has created a late entry to the radioligand party, spending 100 thousand europeans ($ 110 mi...
.After F2G's 1st attempt to obtain a new course of antifungal to market was derailed due to the FDA,...
.Moderna has actually promised to reduce R&D costs by $1.1 billion through 2027. The decision to ...
.Simply four months after Sanofi bet $80 million in upfront cash money on Key Therapies' losmapimod,...